Fat loss still depends on overall calorie balance, activity level, and consistency
Its being investigated in lung cancer as well
Growth is expected to continue, especially with the introduction of the Bridge program, which offers GLP-1 access for obesity with comorbidities under Medicare and Medicaid
Rapid Results: Achieving Significant Weight Loss with Tirzepatide Clinical studies reveal that patients using the medication can achieve remarkable reductions in body mass, with many participants losing between 15% and 20% of their weight over a 72-week period, as shown in the results
In studies, tested doses were: 1 mg 4 mg 8 mg 12 mg weekly (maximum) While the exact dosing plan for retatrutide isnt finalized yet, the overall pattern should feel familiar
Dietary modifications are the cornerstone of managing digestive side effects